Ipamorelin research protocols: selectivity as the defining property

The growth hormone secretagogue class has a clean historical arc. Early compounds worked, then researchers discovered they worked on more than intended. Ipamorelin is what the class looks like after that problem was engineered out.

The selectivity problem it solves

GHRP-6 and GHRP-2, the earlier widely studied secretagogues, act at GHS-R1a, the ghrelin receptor, and reliably stimulate growth hormone release. They also produce measurable elevations in cortisol and prolactin, and GHRP-6 in particular produces a marked appetite response through central ghrelin signalling. For a researcher trying to isolate the effect of GH elevation on a downstream endpoint, those off-target effects are confounds. Cortisol alone influences enough downstream biology to make attribution difficult.

Ipamorelin, a pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2), was characterised as producing GH release comparable to the earlier compounds while leaving cortisol and prolactin essentially at baseline in the published animal models. That is the whole proposition.

Mechanism and the GHRH pairing

Ipamorelin is a GHS-R1a agonist, mimicking ghrelin at the receptor. GHRH analogues such as CJC-1295 No DAC act at a separate receptor, GHRHR. Because the two receptors converge on somatotroph GH release through distinct intracellular routes, simultaneous stimulation produces synergistic release in published work, exceeding what either produces alone. This is the mechanistic basis for the most studied pairing in the growth-axis literature, covered in our stack protocol article. We also supply the pair as a lot-matched blend.

Ipamorelin's half-life is reported around two hours, longer than the GHRH analogue it is usually paired with, which is worth accounting for when designing sampling windows.

Reconstitution for a 10 mg vial

Our Ipamorelin ships as a 10 mg lyophilized vial. The current lot carries a 99.98% HPLC-UV purity result, the highest figure in our catalogue, which is unsurprising for a pentapeptide since coupling efficiency stays high across five residues.

Short peptides like this one are among the most forgiving in handling terms. Ipamorelin tolerates several freeze-thaw cycles with minimal measurable loss, though aliquoting remains best practice for any vial you expect to access more than three times.

Tolerability signals in the literature

The published animal record for ipamorelin is notable primarily for the absence of the cortisol and prolactin elevations that characterise the earlier secretagogues. Observations reported in that literature relate mainly to GH elevation itself rather than to off-target receptor activity. As with every compound in this catalogue, there is no Health Canada authorization and the material is supplied strictly as a laboratory reference standard.

Sourcing and verification

Purity matters more than any protocol detail. A concentration curve computed from a vial that is 88% peptide and 12% truncated sequence is not reproducible, and the failure is invisible until you compare it against another lot. Every Lumera Labs lot ships with a lot-specific certificate of analysis reporting HPLC-UV purity, and those certificates are posted publicly at Lab Results before you order, not emailed afterward. Orders ship from within Canada in 24 to 48 hours, free over $200 CAD, so there is no customs exposure and no multi-week transit window for temperature-sensitive material.

FAQ